Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants
Status:
Active, not recruiting
Trial end date:
2022-03-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of a fixed dose combination of
enalapril (or valsartan), with hydrochlorthiazide, atorvastatin and acetylsalicylic acid
(PolyPill) on primary and secondary prevention of cardiovascular disease in participants of
Pars Cohort of Iran.